Wednesday, October 18, 2023 12:24:26 PM
AI technology is a broad term that refers to the use of artificial intelligence (AI) methods and tools to solve problems, create new products, and enhance existing ones. Plant-based medicines are substances derived from plants that have therapeutic effects on humans or animals.
AI technology and plant-based medicines are both fields that have a lot of potential for innovation and growth. AI technology can help discover new drugs inspired by nature, design novel molecules that have the same effect as natural substances but are easier to manufacture, and match individual patients with the best treatments for their conditions. Plant-based medicines can offer alternative or complementary options for treating various diseases, especially those that are neglected or resistant to conventional drugs.
There are some examples of how AI technology and plant-based medicines are being used or developed in the world today:
A drug molecule invented by AI was used in human trials for the first time in 2020. The drug was created by a British start-up called Exscientia and a Japanese pharmaceutical firm called Sumitomo Dainippon Pharma. The drug was designed to treat patients who have obsessive-compulsive disorder (OCD)1.
A team of researchers at ETH Zurich used AI to recognise the biological activity of natural products and find molecules that mimic their effects. They applied their method to a plant extract that has anti-inflammatory properties and identified a synthetic compound that could be used as a new drug2.
A company called Exscientia also developed a technology that pairs individual patients with the precise drugs they need, taking into account the subtle biological differences between people. They used robotic automation and computer vision to test dozens of treatments on tissue samples from patients and find the best match. They successfully treated a patient with an aggressive form of blood cancer using this approach3.
These are just some of the examples of how AI technology and plant-based medicines are advancing the field of medicine and health care. I think it is fair to say that they are both promising sectors that could have a significant impact on society in the near future.
Recent JAGX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 01:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 11:31:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 01:58:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 01:57:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 01:57:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 01:53:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 01:53:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 01:52:28 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/13/2024 03:02:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:13:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 12:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 10:15:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 09:18:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 04:19:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/31/2024 10:30:50 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/28/2024 10:03:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 10:20:41 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/23/2024 10:05:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:04:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:03:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:02:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:01:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/21/2024 01:02:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 10:41:41 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/10/2024 09:07:07 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM